Literature DB >> 32780278

Real-Time PCR Assays for the Specific Identification of Probiotic Strains Lactobacillus gasseri BNR17 and Lactobacillus reuteri LRC (NCIMB 30242).

Hanan R Shehata1,2, Subramanyam Ragupathy3, Shara Allen4, Gregory Leyer4, Steven G Newmaster3.   

Abstract

The broad spectrum of health benefits attributed to probiotics has contributed to a rapid increase in the value of the probiotic market. Probiotic health benefits can be strain specific. Thus, strain-level identification of probiotic strains is of paramount importance to ensure probiotic efficacy. Both Lactobacillus gasseri BNR17 and Lactobacillus reuteri LRC (NCIMB 30242) strains have clinically proven health benefits; however, no assays were developed to enable strain-level identification of either of these strains. The objective of this study is to develop strain-specific PCR-based methods for Lactobacillus gasseri BNR17 and Lactobacillus reuteri LRC strains, and to validate these assays according to the guidelines for validating qualitative real-time PCR assays. Using RAST (Rapid Annotation using Subsystem Technology), unique sequence regions were identified in the genome sequences of both strains. Probe-based assays were designed and validated for specificity, sensitivity, efficiency, repeatability, and reproducibility. Both assays were specific to target strain with 100% true positive and 0% false positive rates. Reaction efficiency for both assays was in the range of 90 to 108% with R square values > 0.99. Repeatability and reproducibility were evaluated using five samples at three DNA concentrations each and relative standard deviation was < 4% for repeatability and < 8% for reproducibility. Both of the assays developed and validated in this study for the specific identification of Lactobacillus gasseri BNR17 and Lactobacillus reuteri LRC strains are specific, sensitive, and precise. These assays can be applied to evaluate and ensure compliance in probiotic products.

Entities:  

Keywords:  Onsite testing; Probe-based; Probiotics; Real-time PCR; Strain-specific; bCUBE

Mesh:

Year:  2021        PMID: 32780278     DOI: 10.1007/s12602-020-09695-y

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  20 in total

1.  Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults.

Authors:  Mitchell L Jones; Christopher J Martoni; Mathieu Parent; Satya Prakash
Journal:  Br J Nutr       Date:  2011-11-09       Impact factor: 3.718

2.  Lactobacillus gasseri BNR17 Supplementation Reduces the Visceral Fat Accumulation and Waist Circumference in Obese Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Joohee Kim; Jae Moon Yun; Mi Kyung Kim; Oran Kwon; Belong Cho
Journal:  J Med Food       Date:  2018-04-24       Impact factor: 2.786

3.  Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial.

Authors:  M L Jones; C J Martoni; S Prakash
Journal:  Eur J Clin Nutr       Date:  2012-09-19       Impact factor: 4.016

4.  Improvement of gastrointestinal health status in subjects consuming Lactobacillus reuteri NCIMB 30242 capsules: a post-hoc analysis of a randomized controlled trial.

Authors:  Mitchell L Jones; Christopher J Martoni; Jorge G Ganopolsky; Imran Sulemankhil; Peter Ghali; Satya Prakash
Journal:  Expert Opin Biol Ther       Date:  2013-09-28       Impact factor: 4.388

5.  Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes.

Authors:  S I Yun; H O Park; J H Kang
Journal:  J Appl Microbiol       Date:  2009-04-21       Impact factor: 3.772

6.  Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial.

Authors:  Mitchell L Jones; Christopher J Martoni; Satya Prakash
Journal:  J Clin Endocrinol Metab       Date:  2013-04-22       Impact factor: 5.958

Review 7.  Microbial-gut interactions in health and disease. Probiotics.

Authors:  Erika Isolauri; Seppo Salminen; Arthur C Ouwehand
Journal:  Best Pract Res Clin Gastroenterol       Date:  2004-04       Impact factor: 3.043

8.  Genotyping by PCR and High-Throughput Sequencing of Commercial Probiotic Products Reveals Composition Biases.

Authors:  Wesley Morovic; Ashley A Hibberd; Bryan Zabel; Rodolphe Barrangou; Buffy Stahl
Journal:  Front Microbiol       Date:  2016-11-03       Impact factor: 5.640

9.  Effect of Lactobacillus gasseri BNR17 on Overweight and Obese Adults: A Randomized, Double-Blind Clinical Trial.

Authors:  Seung-Pil Jung; Keun-Mi Lee; Ji-Hee Kang; Sung-Il Yun; Han-Oh Park; Yong Moon; Jong-Yeon Kim
Journal:  Korean J Fam Med       Date:  2013-03-20

10.  A double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lactobacillus gasseri BNR17 mitigated diarrhea-dominant irritable bowel syndrome.

Authors:  Suk Pyo Shin; Yoon Mi Choi; Won Hee Kim; Sung Pyo Hong; Jong-Min Park; Joohee Kim; Oran Kwon; Eun Hyun Lee; Ki Baik Hahm
Journal:  J Clin Biochem Nutr       Date:  2018-01-11       Impact factor: 3.114

View more
  2 in total

1.  Identification of novel molecular targets for Weissella species-specific real-time PCR based on pangenome analysis.

Authors:  Eiseul Kim; Seung-Min Yang; Ik-Seon Kim; Hae-Yeong Kim
Journal:  Appl Microbiol Biotechnol       Date:  2022-06-08       Impact factor: 4.813

2.  Locked Nucleic Acid Hydrolysis Probes for the Specific Identification of Probiotic Strains Bifidobacterium animalis subsp. lactis DSM 15954 and Bi-07™.

Authors:  Hanan R Shehata; Anthony Kiefer; Wesley Morovic; Steven G Newmaster
Journal:  Front Microbiol       Date:  2021-12-23       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.